Top Markets
Coin of the day
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals, Inc.

TMBR
Pozycja w akcjach #42059
Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical... Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the research, development, and market introduction of treatments for rare dermatological conditions. The company's key product candidates include: TMB-001, a patented topical isotretinoin formulation, which has successfully completed Phase 2b clinical trials. It is designed to address moderate to severe forms of Congenital Ichthyosis (CI), a group of uncommon genetic disorders affecting skin keratinization. TMB-002, a proprietary topical rapamycin, currently undergoing Phase 2b clinical trials. This therapy targets facial angiofibroma associated with Tuberous Sclerosis Complex, a complex genetic disorder characterized by the growth of benign tumors in multiple organs. TMB-003, a unique Sitaxsentan formulation functioning as a selective endothelin-A receptor antagonist, which is in preclinical development for various sclerotic skin diseases. Additionally, through a licensing agreement with AFT Pharmaceuticals Limited, Timber Pharmaceuticals is advancing two topical minocycline therapies: BPX-01, now in Phase 3 development for treating inflammatory lesions of acne vulgaris. BPX-04, which is prepared for Phase 3 trials, targeting papulopustular rosacea. Founded in 2019, Timber Pharmaceuticals is headquartered in Basking Ridge, New Jersey.
Cena akcji
$0.0101
Ostatnia synchronizacja: 2023-12-26
Kapitalizacja rynkowa
$5.32K
Zmiana (1 dzień)
741.67%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Timber Pharmaceuticals, Inc. (TMBR)

Kategoria

Cena TMBR z kapitalizacją rynkową B
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
TMBR
$0.0101
Kapitalizacja rynkowa Timber Pharmaceuticals, Inc.(TMBR)
Kapitalizacja rynkowa: $5.32K
Na dzień August 2026 spółka Timber Pharmaceuticals, Inc. ma kapitalizację rynkową wynoszącą $5.32K. Według naszych danych, czyni to Timber Pharmaceuticals, Inc. 42059th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Timber Pharmaceuticals, Inc. od 2014 do 2026
TMBR w porównaniu do 5 najpopularniejszych stocks
Cena za TMBR Aktywa B Kapitalizacja rynkowa B Wyniki
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$10,227,038 $5.32K
$5.383T +101,257,803,053.34%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$8,403,338 $5.32K
$4.423T +83,201,368,693.29%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$7,903,663 $5.32K
$4.160T +78,254,084,322.11%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$6,959,394 $5.32K
$3.663T +68,904,895,245.87%
Timber Pharmaceuticals, Inc. Timber Pharmaceuticals, Inc.
$5,492,612 $5.32K
$2.891T +54,382,301,214.11%